An automated controlled-release device for intravaginal hormone delivery.
An automated controlled-release device for intravaginal hormone delivery.
复制标题
DOI:
10.3168/jdsc.2020-18816
复制
发表时间:
2020-08
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Summary: We developed and validated an electronically controlled hormone-delivery device for reproductive control of cattle and demonstrated the feasibility of inducing luteal regression by automated treatment with prostaglandin F2α. On-farm use of this automated delivery system might simplify herd management, reduce animal disruption, and enable improved ovulation synchronization protocols. We developed and validated a fully automated intravaginal hormone-delivery device. Our prototype intravaginal hormone-delivery device successfully induced luteal regression after automated release of PGF2?. Our automated hormone-delivery device may be an alternative tool to current methods for hormone administration. Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF2α. The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = −0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum ≥15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF2α 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF2α released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF2α for successful induction of luteal regression in lactating dairy cows.
登录
查看更多内容
影响因子:
3.6
作者:
Beam, SW;Butler, WR
通讯作者:
Butler, WR
DOI:
10.1016/j.cvfa.2004.06.008
发表时间:
2004-11-01
影响因子:
4.1
作者:
Sheldon, M
通讯作者:
Sheldon, M
影响因子:
2.8
作者:
Ginther, O. J.;Shrestha, H. K.;Beg, M. A.
通讯作者:
Beg, M. A.
影响因子:
5.8
作者:
Cross, PS;Künnemeyer, R;Rathbone, MJ
通讯作者:
Rathbone, MJ
影响因子:
3.5
作者:
Wijma, R.;Stangaferro, M. L.;Giordano, J. O.
通讯作者:
Giordano, J. O.